回答於 : 2024-07-12
Philips' regret over the recall of its devices stems mainly from the impact on patient safety and the distress caused to patients, their families, and care providers. Here's a summary of the key points:
1. **Patient Safety Concerns**:
- Philips discovered potential health risks associated with its CPAP, BiPAP, and ventilator devices due to the degradation of polyester-based polyurethane foam used in these devices. This foam could potentially break down and be inhaled by users, leading to health complications[6].
2. **Distress and Concern**:
- The recall caused significant distress and concern among patients who relied on these devices for their health and wellbeing, as well as among their families and caregivers. Philips expressed regret for the anxiety and inconvenience caused by this recall[2].
3. **Voluntary Recall**:
- The company took proactive steps by initiating a voluntary recall in June 2021, emphasizing their commitment to patient safety. The scale and urgency of this recall highlighted the seriousness of the issue and the company's attempt to mitigate any further risks[3].
In essence, Philips' regret is rooted in the adverse effects on patient safety and the widespread concern and disruption caused by the recall.